Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102030648B details a novel asymmetric dihydroxylation route for high-purity chiral intermediates, offering scalable manufacturing and cost efficiency for cardiovascular drug production.
Patent CN102206170A details a mild, one-pot synthesis of Agomelatine using Nickel Chloride, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102924480B reveals a novel mixed anhydride route for D(-)-sulbenicillin sodium, offering improved solubility and yield for cost reduction in API manufacturing.
Patent CN106432195B reveals a streamlined route for (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, enhancing purity and reducing costs.
Patent CN110684066A reveals a greener T3P-mediated route for Citicoline Sodium, eliminating benzene and phosgene while ensuring >99% purity for reliable API intermediate supply.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Novel silylation-bromination route for high-purity CBD. Stable intermediates ensure supply chain continuity and cost reduction in cannabinoid manufacturing.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102863493B reveals a high-yield beta-thymidine method avoiding corrosive reagents, offering cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN112661611A reveals a novel KI-catalyzed route for Benvitimod, eliminating toxic halogenation and enabling scalable, cost-effective API manufacturing.
Novel immobilized enzyme method for ATP production ensures high purity and stable supply chain for pharmaceutical intermediates manufacturing globally.
Patent CN109180564A reveals a robust synthesis route for fluorinated piperidines offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109180564A reveals novel synthesis for fluoropiperidines. Enhances purity and scalability for pharmaceutical intermediates supply chains globally.
Patent CN105218606B details a phenol-based route for scutellarin. Offers high purity and scalable manufacturing for cardiovascular drug intermediates.
Novel enzymatic resolution method for ambrisentan reduces solvent use and improves yield. Ideal for reliable API intermediate supplier partnerships.
Novel preparation method of Topiroxostat using 4-cyanopyridine and isonicotinic acid. High yield, low cost, suitable for industrial scale-up.
Patent CN104711299B reveals enzymatic adrenaline synthesis. High purity, lower cost, and scalable supply chain solutions for pharmaceutical intermediates manufacturing.
Patent CN115215835A reveals a high-yield two-step Negishi coupling route for isoindoline intermediates, offering significant cost and safety advantages for API manufacturing.
Novel patent CN114685593B offers column-free fulvestrant synthesis. Solid intermediates ensure supply chain stability and cost reduction for pharmaceutical manufacturers seeking reliable partners.
Novel metal-free coupling method for hydrazine derivatives using PIDA. Offers mild conditions and high atom economy for scalable manufacturing.